Certara, Inc., a global leader in biosimulation, announced that 90 percent of new drug approvals by the U.S. Food and Drug Administration’s Center for Drug Evaluation and Review were received by Certara’s customers in 2021, excluding diagnostic agents.
February 15, 2022
· 2 min read